LETAPLIMAB
UNII BDN84I1TFE

Substance Identification & Data

This profile provides standardized clinical and technical data for Letaplimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BDN84I1TFE.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2283356-07-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

BDN84I1TFE

CAS Registry Number

2283356-07-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LETAPLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C157385

National Cancer Institute reference terminology for clinical and research data.

INN ID

11366

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Letaplimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LETAPLIMAB

Common Names & Synonyms

HUMAN ANTI-CD47 MONOCLONAL ANTIBODY (IBI-188)

IMMUNOGLOBULIN G4 (223-PROLINE,229-ALANINE,230-ALANINE,DE-C-TERMINAL-LYSINE), ANTI-(HUMAN CD47 ANTIGEN) (HUMAN MONOCLONAL IBI188 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL IBI188 .KAPPA.-CHAIN, DIMER

LETAPLIMAB [WHO-DD]